This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
10/13/15 - 3:55:45 PM ET (BATS BZX Real-time Price)
Div Yield: --
APPY Day's Range
APPY 52 Week Range
APPY Business Summary
Venaxis, Inc., an in vitro diagnostic company, engages in the development and commercialization of products for unmet diagnostic and therapeutic needs. The company's research, development, and commercial activities primarily focus on a human acute appendicitis blood-based test.View APPY key stats
Venaxis Inc - APPY - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Venaxis Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate VENAXIS INC (APPY) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally disappointing historical performance in the stock itself.